Fulgent Genetics (FLGT) Accumulated Expenses (2015 - 2026)

Fulgent Genetics has disclosed Accumulated Expenses across 12 years of filings, most recently posting $23.5 million for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 8.33% year-over-year to $23.5 million; the TTM figure through Jun 2026 stood at $23.5 million (up 8.33% YoY), while the FY2025 annual figure was $34.1 million, up 40.27% from the prior year.
• Accumulated Expenses came in at $23.5 million for Q2 2026 at Fulgent Genetics, down from $34.9 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $34.9 million in Q1 2026 to a low of $11.8 million in Q1 2022.
• Average Accumulated Expenses over 5 years is $24.4 million, with a median of $24.1 million recorded in 2024.
• Year-over-year, Accumulated Expenses slumped 35.61% in 2025 and jumped 109.13% in 2026.
• Over 5 years, Accumulated Expenses stood at $25.0 million in 2022, then rose by 23.04% to $30.7 million in 2023, then retreated by 21.01% to $24.3 million in 2024, then surged by 40.27% to $34.1 million in 2025, then tumbled by 30.98% to $23.5 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $23.5 million in Q2 2026, $34.9 million in Q1 2026, and $34.1 million in Q4 2025.